UTIs are the cause of roughly 8 million emergency room visits and 100,000 hospitalizations in the US each year, GSK said.

EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved ...

The Advisory Committee on Immunization Practices (ACIP) has voted to expand the recommended use of GSK’s AREXVY (Respiratory ...

The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has ...

In a report released today, Jo Walton from UBS maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of ...

Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2025, the company has a total of 16.94 Crore shares outstanding.GSK Pharma Share Price Today is Rs. 2818.20. On previous day, the ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...

GSK PLC closed 25.31% below its 52-week high of £18.24, which the company reached on May 16th.

Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

China’s response to new United States (U.S.) tariffs could complicate the supply of important medicines, an analysis of data ...

U.K. regulators cleared a multiple myeloma drug GSK withdrew from market three years ago. Elsewhere, an investment firm pressed Elevation Oncology to liquidate and the FDA relaxed risk monitoring ...